Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Proper Extent of Maze Intercaval Lesion (Maze)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03091205
Recruitment Status : Withdrawn (Unable to obtain funding source)
First Posted : March 27, 2017
Last Update Posted : May 30, 2018
Sponsor:
Information provided by (Responsible Party):
Baylor Research Institute

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
It's hypothesized that a mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue can be measured to better inform surgeons performing the Cox-Maze procedure. A patient scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible could be entered into the study if they meet the inclusion/exclusion requirements.

Condition or disease
Atrial Fibrillation

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Proper Extent of Maze Intercaval Lesion
Estimated Study Start Date : April 15, 2018
Estimated Primary Completion Date : April 15, 2019
Estimated Study Completion Date : April 15, 2019

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Distance until complete loss of conductive tissue [ Time Frame: 6 Months ]
    To measure the mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible
Criteria

Inclusion Criteria:

  • Age ≥ 18 years male or female
  • Scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible
  • Subjects willing and able to provide written informed consent

Exclusion Criteria:

  • Subjects receiving surgery with non-sternotomy access
  • Presence of or history of transvenous pacing leads
  • Subjects receiving a re-do cardiac surgery
  • Subjects with a history of pericarditis
  • Subjects who are in atrial fibrillation or atrial flutter and cannot be converted out of it.
  • Any medical condition or finding for which the Investigator used medical discretion to determine the subject should be excluded
  • Subject is currently participating in another clinical trial.
  • Subject is unable to provide written informed consent.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03091205


Locations
Layout table for location information
United States, Texas
The Heart Hospital Baylor Plano
Plano, Texas, United States, 75093
Sponsors and Collaborators
Baylor Research Institute
Investigators
Layout table for investigator information
Principal Investigator: Timothy George, M.D Baylor Reasearch Institute
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Baylor Research Institute
ClinicalTrials.gov Identifier: NCT03091205    
Other Study ID Numbers: 017-048
First Posted: March 27, 2017    Key Record Dates
Last Update Posted: May 30, 2018
Last Verified: May 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes